Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

8.28
-1.1400-12.10%
Post-market: 8.280.00000.00%17:39 EDT
Volume:2.60M
Turnover:21.78M
Market Cap:936.64M
PE:-2.46
High:9.40
Open:9.09
Low:8.15
Close:9.42
Loading ...

Dyne Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
03 Mar

Dyne Therapeutics (DYN) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
02 Mar

Morgan Stanley Keeps Their Buy Rating on Dyne Therapeutics (DYN)

TIPRANKS
·
28 Feb

Dyne Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
28 Feb

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Dyne Therapeutics (DYN) and Kymera Therapeutics (KYMR)

TIPRANKS
·
28 Feb

Dyne Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
28 Feb

RBC Cuts Price Target on Dyne Therapeutics to $41 From $45, Keeps Outperform, Speculative Risk

MT Newswires Live
·
28 Feb

Buy Rating for Dyne Therapeutics: Promising Accelerated Approval Potential for DYNE-101 and DYNE-251

TIPRANKS
·
28 Feb

Dyne Therapeutics price target lowered to $46 from $55 at H.C. Wainwright

TIPRANKS
·
28 Feb

Dyne Therapeutics Advances Clinical Programs Amid Financial Losses

TIPRANKS
·
28 Feb

Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise

MT Newswires Live
·
27 Feb

Earnings Flash (DYN) Dyne Therapeutics Reports Q4 Loss $0.88, vs. FactSet Est of $0.94 Loss

MT Newswires Live
·
27 Feb

Corrected-Dyne Therapeutics Q4 EPS USD -0.88 VS. Ibes Estimate USD -0.96 (Corrects Amount)

THOMSON REUTERS
·
27 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Feb

Jefferies Group's Strategic Moves: Amazon.com Inc. Takes Center Stage with 2.28% Portfolio Impact

GuruFocus.com
·
15 Feb

After Plunging -10.43% in 4 Weeks, Here's Why the Trend Might Reverse for Dyne Therapeutics (DYN)

Zacks
·
13 Feb

Dyne Therapeutics, Inc. (DYN): Among the Best Rebound Stocks to Invest In Now

Insider Monkey
·
06 Feb

Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol

Zacks
·
03 Feb

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era

Zacks
·
31 Jan

Down -42.2% in 4 Weeks, Here's Why Dyne Therapeutics (DYN) Looks Ripe for a Turnaround

Zacks
·
28 Jan